E. coli growth inhibition by amniotic fluid. 1976

C Prevedourakis, and E Koumentakou, and J Zolotas, and T Zolotas, and A Xygakis, and I Kotoulas

Amniotic fluid samples were collected aseptically from 29 normal pregnancies, between the 38th and 41st week of gestation and checked for sterility in the laboratory, in order to investigate in vitro the effect of the liquor on the growth of E. coli. Brain Heart Infusion (B.H.I.) and Ringer solution were used as controls. E. coli cultures were inoculated in amniotic fluid, B.H.I., Ringer solution and amniotic fluid plus B.H.I. and incubated at 37degreesC for 48 hours. At 0, 1, 3, 6, 12, 24, 36 and 48 hours of incubation, surface viable counts were performed to estimate the number of E. coli viable cells. The growth of E. coli in B.H.I. started furing the 1st hours after inoculation and continued over 48 hours; in Ringer solution the mean growth curve and almost identical to that of B.H.I. In amniotic fluid the growth of E. coli began from the 1st hour of inoculation but the growth curve was much lower, became static in 24 hours and a permanent inhibition was observed thereafter. The addition of a small amount of B.H.I. in amniotic fluid enhanced the growth of E. coli, but the growth curve was lower in comparison to the curves of the two controls studied. In conclusion, after 48 hours of inoculation in amniotic fluid, 26 of the 29 cases showed bacteriostatic or bactericidal activity of the liquor upon the growth of E. coli.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000653 Amniotic Fluid A clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS). Amniotic Fluid Index,Amniotic Fluid Indices,Amniotic Fluids,Fluid Index, Amniotic,Fluid Indices, Amniotic,Fluid, Amniotic,Fluids, Amniotic,Index, Amniotic Fluid,Indices, Amniotic Fluid

Related Publications

C Prevedourakis, and E Koumentakou, and J Zolotas, and T Zolotas, and A Xygakis, and I Kotoulas
January 1973, Obstetrics and gynecology,
C Prevedourakis, and E Koumentakou, and J Zolotas, and T Zolotas, and A Xygakis, and I Kotoulas
February 1974, Obstetrics and gynecology,
C Prevedourakis, and E Koumentakou, and J Zolotas, and T Zolotas, and A Xygakis, and I Kotoulas
May 1977, American journal of obstetrics and gynecology,
C Prevedourakis, and E Koumentakou, and J Zolotas, and T Zolotas, and A Xygakis, and I Kotoulas
June 1974, American journal of obstetrics and gynecology,
C Prevedourakis, and E Koumentakou, and J Zolotas, and T Zolotas, and A Xygakis, and I Kotoulas
October 1965, American journal of obstetrics and gynecology,
C Prevedourakis, and E Koumentakou, and J Zolotas, and T Zolotas, and A Xygakis, and I Kotoulas
August 1975, The New England journal of medicine,
C Prevedourakis, and E Koumentakou, and J Zolotas, and T Zolotas, and A Xygakis, and I Kotoulas
August 1975, American journal of obstetrics and gynecology,
C Prevedourakis, and E Koumentakou, and J Zolotas, and T Zolotas, and A Xygakis, and I Kotoulas
December 1968, American journal of obstetrics and gynecology,
C Prevedourakis, and E Koumentakou, and J Zolotas, and T Zolotas, and A Xygakis, and I Kotoulas
October 1999, Bioorganic & medicinal chemistry letters,
C Prevedourakis, and E Koumentakou, and J Zolotas, and T Zolotas, and A Xygakis, and I Kotoulas
September 1985, Journal of general microbiology,
Copied contents to your clipboard!